ARCHIVES

FDA Softening Its Stance On CME Guidelines; New Version To Be More In Line with ACCME

This article is from The Cancer Letter archive.

Vol. 18 No. 14 | April 3, 1992

Download PDF Visit The Full Archive

Related Articles

Scientific Program Organized For XIIIth Cancer Congress

October 2, 1981

Senate Approves $1 Billion For NCI

July 27, 1979

Nobel Laureate Gilman Prepares to Leave The Texas Cancer Agency—Can it Survive?

September 28, 2012

STAR Begins: Critics of Trial Call For Including A Placebo Arm

June 4, 1999

Maxine Singer Wins Top SES Award

January 8, 1988

NCS Heeds Bloch’s Plea, To Consider Establishing Separate PDQ-Like System For General Public Use

December 7, 1984